Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

Life can change in the blink of an eye. For Alix Schneider, this reality struck during a routine day when an unpredict ...

The Food and Drug Administration (FDA) has recently approved an innovative obesity medication from Eli Lilly that hold ...

The move is aimed at helping Americans navigate food labels at the grocery store and make choices that are aligned with ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

The Food and Drug Administration has told food manufacturers the psychoactive mushroom Amanita muscaria isn't authorized for ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The Food and Drug Administration has approved Zepbound to treat obstructive sleep apnea for people who are moderately or ...

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

The move is aimed at helping Americans navigate food labels at the grocery store and make choices that are aligned with ...

Novo Nordisk (NVO) wins U.S. FDA nod for its Alhemo injection as a once-daily prophylaxis for bleeding prevention in patients ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.